Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) reported the earnings of $0.28/Share in the last quarter where the estimated EPS by analysts was $0.27/share. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 3.7%.
Many analysts are providing their Estimated Earnings analysis for Sucampo Pharmaceuticals, Inc. and for the current quarter 6 analysts have projected that the stock could give an Average Earnings estimate of $0.49/share. These analysts have also projected a Low Estimate of $0.47/share and a High Estimate of $0.5/share.
In case of Revenue Estimates, 7 analysts have provided their consensus Average Revenue Estimates for Sucampo Pharmaceuticals, Inc. as 65.95 Million. According to these analysts, the Low Revenue Estimate for Sucampo Pharmaceuticals, Inc. is 64.5 Million and the High Revenue Estimate is 68.2 Million. The company had Year Ago Sales of 55.37 Million.
Some buy side analysts are also providing their Analysis on Sucampo Pharmaceuticals, Inc., where 1 analysts have rated the stock as Strong buy, 4 analysts have given a Buy signal, 3 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. 8 Analysts reported that the Price Target for Sucampo Pharmaceuticals, Inc. might touch $29 high while the Average Price Target and Low price Target is $19.88 and $13 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. Sucampo Pharmaceuticals, Inc. got Initiated on 7-Sep-16 where investment firm Northland Capital Initiated the stock to Outperform.
Sucampo Pharmaceuticals, Inc. closed its last trading session at $16.15 with the gain of 6.19%. The Market Capitalization of the company stands at 785.98 Million. The Company has 52-week high of $18.75 and 52-week low of $9.59. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 21.42% where SMA50 and SMA200 are 29.03% and 43.38% respectively. The Company Touched its 52-Week High on Dec 23, 2015 and 52-Week Low on Mar 17, 2016.
The Relative Volume of the company is 3.85 and Average Volume (3 months) is 367.84 million. Sucampo Pharmaceuticals, Inc. P/E (price to earnings) ratio is 57.55 and Forward P/E ratio of 10.18.
The company shows its Return on Assets (ROA) value of 2.9%. The Return on Equity (ROE) value stands at 11.7%. While it’s Return on Investment (ROI) value is 10.1%.
While looking at the Stock’s Performance, Sucampo Pharmaceuticals, Inc. currently shows a Weekly Performance of 9.58%, where Monthly Performance is 47.21%, Quarterly performance is 55.77%, 6 Months performance is 39.89% and yearly performance percentage is 0%. Year to Date performance value (YTD perf) value is -0.81%. The Stock currently has a Weekly Volatility of 6.31% and Monthly Volatility of 7.34%.